Oliver Wyman Health Innovation Summit 2017

Chris Cigarran is the CEO of Imagine Health, the nation’s leading provider of exclusive provider networks for self-insured employers. Prior to joining Imagine Health, he spent thirteen years at Healthways, serving in multiple executive leadership roles. Cigarran received his undergraduate degree from Bucknell University and his Master’s in Organization Development from the Graziadio School of Business at Pepperdine University.

Niyum Gandhi is the Executive Vice President and Chief Population Health Officer of the Mount Sinai Health System. He oversees Mount Sinai’s transition from a primarily fee-for-service model of care to one that focused on value and risk-based population health. Gandhi’s team is responsible for aligning the Health System’s clinical and economic transformations in support of Mount Sinai’s vision to be the leading population health manager in the New York market. This includes fostering care management and clinical redesign to ensure that high-value care is delivered across the Health System, and working with payers and employers to establish the new economic models that support value-based care.

An author and entrepreneur, Thomas Goetz is the co-founder of Iodine, an online health resource that helps millions of people find the best medical treatment. In 2016, Iodine was acquired by GoodRx, the nation’s leading source for medication savings. Previously he served as executive editor at WIRED, where he led the magazine to a dozen National Magazine Awards for print and digital excellence from 2001 through 2012. His latest book, The Remedy, about the quest to cure tuberculosis, was chosen by Amazon as a Best Book of 2014. His previous book, The Decision Tree, was chosen by the Wall Street Journal as a Best Book of 2010, and widely hailed as offering a new vision for healthcare in the United States. His writing has been repeatedly selected for the Best American Science Writing and Best Technology Writing anthologies. He has served as the first Entrepreneur-in-Residence for the Robert Wood Johnson Foundation, and the Curator-in-Residence for Adobe Systems. His 2010 TED talk on visualizing medical data has been viewed half a million times. Thomas also writes the LaunchPad column for Inc. Magazine. Goetz holds a Master of Public Health degree from the University of California, Berkeley, and a Master's in American literature from the University of Virginia. He graduated from Bates College, and plays the cello.

Deb Gold serves as Senior Vice President of Market Strategy and Consultant Relations, keeping Quantum Health abreast of market trends and enhancing consultant channel partner relations at leadership levels. Gold retired as a Senior Partner from Mercer, a global benefits consulting firm. She held a variety of roles over her 15-year tenure, including U.S. National Leader for Health and Productivity Management, Chicago office, and Midwest Health & Benefits Market Leader. She served as a consultant for some of the firm’s largest and most complex accounts. In her 30 years in healthcare, Gold was Executive Vice President at CorSolutions, a health and disease management company acquired by Matria/Alere. She was also Partner at Towers Perrin, now Willis Towers Watson, and Director of Account Management at United Healthcare. Gold has an MBA from the Wharton School at the University of Pennsylvania, a Master of Arts from the University of Florida and a Bachelors of Science from the University of Wisconsin.

David Holmberg is President and CEO of Highmark Health, a national health and wellness enterprise based in Pittsburgh, Pa., that serves nearly 50 million people nationwide. He also serves as Chairman of the Board of Highmark Inc., the health insurance affiliate of Highmark Health, as well as the Board of Directors of the Blue Cross Blue Shield Association and American Health Insurance Plans. Holmberg is active in his community and supports several causes. He serves on the Board of Directors of the Allegheny Conference on Community Development and the Pittsburgh Cultural Trust.

As CEO of AARP, Jo Ann Jenkins leads the world’s largest non-profit, nonpartisan membership organization with nearly 38 million members. Since 2014, Jenkins has transformed AARP into a leader in social change dedicated to enhancing quality of life for all as we live and age. Jenkins began her career with the U.S. Department of Housing and Urban Development, later moving to the U.S. Department of Transportation and U.S. Department of Agriculture and then served as Chief Operating Officer of the Library of Congress. In 2015 Jenkins was recognized as “Non-Profit Influencer of the Year”. Most recently, she is the best-selling author of Disrupt Aging: A Bold New Path to Living Your Best Life at Every Age. After earning her BS degree from Spring Hill College in Mobile, Alabama, Jo Ann graduated from the Stanford Graduate School of Business Executive Program. Jenkins also holds an Honorary Doctorate of Humane Letters from both Spring Hill College and Washington College.

Stephen Klasko is President and CEO of Thomas Jefferson University and Jefferson Health, one of the fastest growing academic health centers in the nation. An advocate for transformational change in health care, he is author of 2016’s “We Can Fix Healthcare in America: The Future Is Now,” and Editor in Chief of the journal Healthcare Transformation. A native of Philadelphia, he returned in 2013 to lead Jefferson on a growth strategy to more than double its health care delivery, and to create a comprehensive professional university.

Sarah Krevans leads Northern California-based Sutter Health, a not-for-profit health system caring for 3 million patients—or one in every 100 Americans. Following her service as deputy director of Maine’s Bureau of Medical Services and acting director of Medicaid, health planning and licensure programs, she moved to California in 1987 where she held increasingly responsible positions at Kaiser Permanente. Krevans joined Sutter Health in 1999 as Senior Vice President of Managed Care. From 2000 to 2011, she served as Regional Executive Officer and President of the Sutter Health Sacramento Sierra Region. From 2012 to 2015, Krevans served as Sutter Health’s Chief Operating Officer, and in January 2016 became President and CEO. Under her leadership, in 2016, Sutter Health and Sutter’s Valley Area were named among America’s top five large health systems by Truven Health Analytics.

Chris is the CEO and co-founder of Skymind, an open-source artificial intelligence company backed by Tencent and Y Combinator. Skymind is Red Hat for AI, and it is currently building several AI applications for healthcare. In a prior life, Chris worked as a journalist for over a decade, reporting on business for The New York Times, the International Herald Tribune, and Bloomberg Businessweek. In the technology sector, he served as head of communications and recruiting for the Sequoia-backed robo-advisor FutureAdvisor.

Nigel Morris is the Co-Founder and Managing Partner of QED Investors, a direct investment fund focused on high-growth companies in fintech. Morris and the QED team are world-renowned for their prowess in the consumer technology and lending spaces – as evidenced by QED’s early stage investments in numerous industry leaders including Credit Karma, ClearScore, Transunion, SoFi, Green Sky, Avant, China Rapid Finance, Prosper, and Media Math. Prior to venture investing, Morris co-founded Capital One Financial Services in 1994. Under his leadership as President and Chief Operating Officer, Capital One pioneered an information based strategy that fundamentally transformed the lending industry.

Dr. Paul Rothman is the Dean of the Medical Faculty for the Johns Hopkins University School of Medicine and CEO of Johns Hopkins Medicine, a $8 billion academic medical enterprise and a health system with a global reach. As Dean and CEO, Rothman oversees both the Johns Hopkins Health System and the School of Medicine. A rheumatologist and molecular immunologist, he came to Hopkins in July 2012 after having served as Dean of the Carver College of Medicine at the University of Iowa and leader of its clinical practice plan since 2008. Previously, he served as Head of Internal Medicine at the University of Iowa, beginning in 2004, and prior to that as Vice Chairman for Research and Founding Director of the Division of Pulmonary, Allergy and Critical Care Medicine at Columbia University College of Physicians and Surgeons. A 1980 Phi Beta Kappa graduate of the Massachusetts Institute of Technology, Rothman received his Medical degree from Yale University in 1984.

Lauren Silverman is the Health, Science and Technology reporter/blogger at KERA News. In 2016, Silverman was recognized as Texas Health Journalist of the Year by the Texas Medical Association. She was part of the Peabody Award-winning team that covered Ebola for NPR in 2014. She also hosted "Surviving Ebola," a special that won Best Long Documentary honors from the Public Radio News Directors Inc. (PRNDI). And she's won a number of regional awards, including an honorable mention for Edward R. Murrow award (for her project “The Broken Hip”), as well as the Texas Veterans Commission’s Excellence in Media Awards in the radio category.

Lisa Suennen is Senior Managing Director at GE Ventures leading the firm’s healthcare venture fund which invests in early-to-growth stage healthcare investments across health IT, health services, medical technology and life science technologies. Suennan is also Managing Partner at Venture Valkyrie, a media and publishing company, and co-founder of CSweetener, a not-for-profit company focused on matching women in and nearing the healthcare C-Suite with mentors who have been there and wish to give back. She is a member of the faculty at the UC Berkeley Haas School of Business, where for 10 years she has taught classes on venture capital and the changing healthcare economy.

Marilyn Tavenner is President & CEO of America's Health Insurance Plans (AHIP). AHIP’s members provide coverage for health care and related services to millions of Americans daily. Through these offerings, they improve and protect the health and financial security of consumers, families, businesses, communities and the nation. Tavenner served as administrator/principal deputy administrator of the Centers for Medicare & Medicaid Services (CMS) from 2010-2015. Prior to that, she served as Secretary of Health and Human Resources in the cabinet of Governor Tim Kaine from 2006-2010. She also served as CEO of the Hospital Corporation of America beginning in 1993.

Todd VanTol is the Senior Vice President of Health Plan Business for Blue Cross Blue Shield of Michigan (BCBSM). He has responsibility for the plan’s Autos, Key & Large, Middle & Small Group, and Private Exchange lines of business. Todd also leads the Sales Strategy & Operations for their Commercial business. Prior to joining BCBSM in July of 2017, Todd served as a Partner and North American practice leader for the Health & Life Sciences practice of Oliver Wyman where he led the firm’s efforts across Payer and Provider clients. Prior to Oliver Wyman, Todd held senior roles at the Blue Cross Blue Shield Association as well as Bain & Company. His experience spans a broad range of strategic issues facing health plans and providers including market reform planning, customer strategy, building new value-based payer/provider partnership models, and the development of next generation product offerings. Todd VanTol is the Senior Vice President of Health Plan Business for Blue Cross Blue Shield of Michigan (BCBSM). In that role, he has responsibility for the plan’s Autos, Key & Large, Middle & Small Group, and Private Exchange lines of business. He also leads the Sales Strategy & Operations for their Commercial business. Prior to joining BCBSM in July of 2017, Todd served as a Partner and North American practice leader for the Health & Life Sciences business of Oliver Wyman where he led the firm’s efforts across Payer and Provider clients. Prior to Oliver Wyman, VanTol held senior roles at the Blue Cross Blue Shield Association as well as Bain & Company. His experience spans a broad range of strategic issues facing health plans and providers including market reform planning, customer strategy, building new value-based payer/provider partnership models, and the development of next generation product offerings. He holds an MBA from the University of Michigan and a BS from Michigan State University.

Mike Weissel is a Group Executive Vice President responsible for corporate and business strategy, product development and solutioning across Optum. In this role he focuses on cross Optum initiatives, strategy and the development of integrated offerings for the marketplace. Mike joined Optum in 2013 as executive vice president and for three years was the CEO of Optum’s Consumer Solutions Group. The Consumer Solutions Group included all of Optum’s population health management, financial services and distribution products. Prior to joining Optum, Mike was with leading international management consulting firm Oliver Wyman for 17 years. He founded Oliver Wyman’s Health & Life Sciences practice in 2007, and served as managing partner and global leader for that practice until 2013. Prior to Oliver Wyman, Mike was a Certified Public Accountant and associate partner at Price Waterhouse.

Dr. Krishna Yeshwant is a physician, programmer and entrepreneur who has been working with GV [previously Google Ventures] since its inception. He first joined Google as part of the New Business Development team. Prior to Google, Dr. Yeshwant helped start an electronic data interchange company that was acquired by Hewlett-Packard and a network security company that was acquired by Symantec. Dr. Yeshwant has a B.S. in computer science from Stanford University. He also earned an M.D. from Harvard Medical School, an M.B.A. from Harvard Business School, and completed his residency at Brigham and Women’s Hospital in Boston, MA where he continues to practice.

Critical to the success of consumer-focused offerings is their ability to effectively address consumers' underlying needs: what they're ultimately trying to accomplish through the purchase. For decades, we've relied upon demographic 'stats' to improve offerings - but does this mechanism, which by definition stereotypes individuals based on superficial traits, help uncover why consumers make the decisions they make? This session examines how the underlying causes of consumer behavior impact the propensity to buy through one of the most prominent theories of causality – Jobs to be Done – and explores how this understanding informs better products that drive an enhanced consumer experience.

If there’s one thing people can agree on around how a drug is valued, it’s that no two stakeholders agree on how best to approach it. Healthcare is rapidly shifting to value; specialized medicine is delivering remarkable new therapies; and dissatisfaction around drug prices is growing. It is more imperative now than ever before for each stakeholder – including health plans, pharma, government, providers, innovators, employers – to understand each other’s perspectives. This session will explore the rationale behind multiple stakeholders’ approaches to value – and kick-start a discussion aimed to develop a shared definition of value.

The distribution landscape has seen significant proliferation in recent years, from private exchanges and PEOs, to consumer-direct platforms and brick and mortar retail. But the traditional, well-calibrated B2B broker/consultant model still dominates the industry's trading flow. How close are we to the tipping point of a distribution disruption where the focus shifts to employee experience? What B2B2C value proposition needs to be in place, what needs should be met, and what technical requirements are necessary, in order to create a seismic shift? Who will control the customer experience in the future? This session will address these questions from the voices of the employer, stakeholders in the traditional model, and the new digital distribution players.

'High-tech' models use digital technology to reach and engage with millions. 'High-touch' models leverage human interactions to create high-trust relationships and incredible impact. Does each model have its own universe? How do you take the capabilities of each of these models and make them relevant and impactful in the other? The session will tackle a major tension in healthcare: Can the industry deliver far greater impact by leveraging the 'best of' across the spectrum to develop a scalable model that drives the best outcomes?

Affordability has been a longstanding hot topic in healthcare. Nonetheless, costs continue to rise - on every measure. Population health and value-based models offer a slow-to-come promise. The demand for care remains excessive; the costs to supply care stay prohibitive. This session combats affordability from the demand side and the supply side: Will Precision Medicine and AI dramatically reduce demand - thus justifying their costs? Will digitization and automation replicate their transformative impact on productivity in healthcare - radically lowering delivery costs without overcomplicating IT systems? Which side will take the driver's seat to lead us to truly affordable care?

Many innovative start-ups have entered the healthcare industry in recent years, claiming to be the driving force behind more affordable and more effective healthcare. What are the incumbents doing to retain their impact? How are they leveraging technology to deliver more affordable care, create better consumer experience, and ultimately enable better outcomes? This session takes you through the journeys of two legacy players – and discovers how they took matters into their own hands to tackle the industry’s biggest problems.

The healthcare industry is struggling to adapt to a world rampant with advanced technologies and innovations. Companies need to evolve to survive the disruptions and to reap the benefits of these advancements. What structures, mindset, and behaviors, do incumbents need to reinvent themselves to be "disruption-ready"? What are the distinctive characteristics of organizations that are prepared to embrace innovations and have the agility and flexibility to react to changes quickly? This session presents an out-of-industry enterprise that has successfully reinvented itself, and explores what a healthcare business needs to do to replicate the same success.

In industries ranging from manufacturing to automotive, and video gaming to financial services, Artificial Intelligence is increasing accuracy and efficiency while improving consumer experience. What about health? Is there a future where patients prefer getting advice from a robot over their PCP? How close are we to perfect diagnoses? This session examines AI's role in the healthcare industry - from prevention to intervention, from machine learning to patient facing - and questions how futuristic AI really is.